Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells.

Abstract:

:Chronic graft-versus-host disease (cGVHD) is characterized by a state of profound immunodeficiency in association with alloreactive and autoimmune phenomena. These observations indicate an impairment of immunologic tolerance that could involve both central and peripheral mechanisms. Defective thymic function may contribute to dysregulation of central tolerance, but few studies have addressed peripheral tolerance. Recently a population of CD4+CD25+ T cells (Treg cells) has been characterized, which controls immunologic reactivity in vivo and which on transfer can prevent experimental acute GVHD. We investigated the number and function of peripheral blood CD4+CD25high T cells in patients more than 100 days after allogeneic hematopoietic stem cell transplantation. Patients with cGVHD had markedly elevated numbers of CD4+CD25high T cells as compared to patients without GVHD. CD4+CD25high T cells derived from patients in both groups were of donor origin, lacked markers of recent activation, and expressed intracellular CD152. In contrast to controls, CD4+CD25high T cells derived from patients with cGVHD were characterized by lower surface CD62L expression. In vitro, CD4+CD25high T cells were hyporesponsive to polyclonal stimulation and suppressed the proliferation and cytokine synthesis of CD4+CD25- cells, an effect that was independent of interleukin 10. These results indicate that chronic graft-versus-host injury does not occur as a result of Treg cell deficiency.

journal_name

Blood

journal_title

Blood

authors

Clark FJ,Gregg R,Piper K,Dunnion D,Freeman L,Griffiths M,Begum G,Mahendra P,Craddock C,Moss P,Chakraverty R

doi

10.1182/blood-2003-06-2073

subject

Has Abstract

pub_date

2004-03-15 00:00:00

pages

2410-6

issue

6

eissn

0006-4971

issn

1528-0020

pii

2003-06-2073

journal_volume

103

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

    abstract::A series of alterations in the cellular genome affecting the expression or function of genes controlling cell growth and differentiation is considered to be the main cause of cancer. These mutational events include activation of oncogenes and inactivation of tumor suppressor genes. The elucidation of human cancer at t...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Reuter CW,Morgan MA,Bergmann L

    更新日期:2000-09-01 00:00:00

  • Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.

    abstract::Acute myeloid leukemia (AML) is one of the most common acute leukemias in adults and children, yet significant numbers of patients relapse and die of disease. In this study, we identify the dependence of AML blasts on arginine for proliferation. We show that AML blasts constitutively express the arginine transporters ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-09-600643

    authors: Mussai F,Egan S,Higginbotham-Jones J,Perry T,Beggs A,Odintsova E,Loke J,Pratt G,U KP,Lo A,Ng M,Kearns P,Cheng P,De Santo C

    更新日期:2015-04-09 00:00:00

  • Leukocyte trafficking in a mouse model for leukocyte adhesion deficiency II/congenital disorder of glycosylation IIc.

    abstract::Leukocyte adhesion deficiency II (LAD II), also known as congenital disorder of glycosylation IIc (CDG-IIc), is a human disease in which a defective GDP-fucose transporter (SLC35C1) causes developmental defects and an immunodeficiency that is based on the lack of fucosylated selectin ligands. Since the study of in viv...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-132035

    authors: Yakubenia S,Frommhold D,Schölch D,Hellbusch CC,Körner C,Petri B,Jones C,Ipe U,Bixel MG,Krempien R,Sperandio M,Wild MK

    更新日期:2008-08-15 00:00:00

  • High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

    abstract::Single-center experiences have shown that intensified treatments with autologous transplantation are a promising therapeutic strategy for patients with high-risk follicle-center lymphoma (FCL) at diagnosis, whereas data from prospective multicenter trials are still lacking. This paper describes the results of a prospe...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2002-02-0621

    authors: Ladetto M,Corradini P,Vallet S,Benedetti F,Vitolo U,Martelli M,Brugiatelli M,Coser P,Perrotti A,Majolino I,Fioritoni G,Morandi S,Musso M,Zambello R,Chisesi T,Di Renzo N,Vivaldi P,De Crescenzo A,Gallamini A,Salvi F,

    更新日期:2002-09-01 00:00:00

  • Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report.

    abstract::We treated 109 patients with adult acute lymphoblastic leukemia (ALL) diagnosed by histochemical and immunologic techniques. Patients were excluded only for age greater than 50 years and Burkitt's leukemia. Treatment included a four-drug remission induction phase followed by alternating cycles of noncrossresistant che...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Linker CA,Levitt LJ,O'Donnell M,Forman SJ,Ries CA

    更新日期:1991-12-01 00:00:00

  • Distribution of dehydration rates generated by maximal Gardos-channel activation in normal and sickle red blood cells.

    abstract::The Ca(2+)-activated K+ channels of human red blood cells (RBCs) (Gardos channels, hIK1, hSK4) can mediate rapid cell dehydration, of particular relevance to the pathophysiology of sickle cell disease. Previous investigations gave widely discrepant estimates of the number of Gardos channels per RBC, from as few as 1 t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-01-0125

    authors: Lew VL,Tiffert T,Etzion Z,Perdomo D,Daw N,Macdonald L,Bookchin RM

    更新日期:2005-01-01 00:00:00

  • Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1.

    abstract::Murine IgM monoclonal antibody STRO-1 identifies a cell surface antigen expressed by stromal elements in human bone marrow (BM). STRO-1 binds to approximately 10% of BM mononuclear cells, greater than 95% of which are nucleated erythroid precursors, but does not react with committed progenitor cells (colony-forming un...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Simmons PJ,Torok-Storb B

    更新日期:1991-07-01 00:00:00

  • Endothelial CD99 supports arrest of mouse neutrophils in venules and binds to neutrophil PILRs.

    abstract::CD99 is a crucial regulator of the transmigration (diapedesis) of leukocytes through the blood vessel wall. Here, we report that CD99 acts at 2 different steps in the extravasation process. In agreement with previous antibody-blocking experiments, we found that CD99 gene inactivation caused neutrophil accumulation bet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-08-733394

    authors: Goswami D,März S,Li YT,Artz A,Schäfer K,Seelige R,Pacheco-Blanco M,Jing D,Bixel MG,Araki M,Araki K,Yamamura KI,Vestweber D

    更新日期:2017-03-30 00:00:00

  • Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3.

    abstract::Follicular lymphoma (FL) grades 1 and 2 are regarded as a distinct disease entity, whereas data suggest that FL grade 3 might be an inhomogeneous tumor category. To define the biologic spectrum of FL, 89 follicular lymphomas were studied for their cytologic composition, antigen expression, mitotic and proliferation in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.10.3806

    authors: Ott G,Katzenberger T,Lohr A,Kindelberger S,Rüdiger T,Wilhelm M,Kalla J,Rosenwald A,Müller JG,Ott MM,Müller-Hermelink HK

    更新日期:2002-05-15 00:00:00

  • Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.

    abstract::Type 1 T regulatory (Tr1) cells suppress immune responses in vivo and in vitro and play a key role in maintaining tolerance to self- and non-self-antigens. Interleukin-10 (IL-10) is the crucial driving factor for Tr1 cell differentiation, but the molecular mechanisms underlying this induction remain unknown. We identi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-07-234872

    authors: Gregori S,Tomasoni D,Pacciani V,Scirpoli M,Battaglia M,Magnani CF,Hauben E,Roncarolo MG

    更新日期:2010-08-12 00:00:00

  • Lymphoma invisibility-vaccination-attack?

    abstract::In this issue of Blood, Navarrete et al report that upfront immunization of follicular B-cell lymphoma patients with bacterially produced Fab fragments induces immune responses; however, the influence on patient outcome is not yet known. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2010-11-318469

    authors: Bogen B

    更新日期:2011-02-03 00:00:00

  • Sickle cell and silent spleen.

    abstract::In this issue of Blood, in a first-rate example of collaboration between academia (University of California) and industry (Sangamo), Hoban et al show in situ gene correction of sickle cell anemia (SCA), a prototypical hemoglobinopathy. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-03-633933

    authors: Tolar J

    更新日期:2015-04-23 00:00:00

  • How I treat myelodysplastic syndromes of childhood.

    abstract::Pediatric myelodysplastic syndromes (MDSs) are a heterogeneous group of clonal disorders with an annual incidence of 1 to 4 cases per million, accounting for less than 5% of childhood hematologic malignancies. MDSs in children often occur in the context of inherited bone marrow failure syndromes, which represent a pec...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-09-765214

    authors: Locatelli F,Strahm B

    更新日期:2018-03-29 00:00:00

  • The reversible binding of vinblastine to platelets: implications for therapy.

    abstract::The ability of platelets to adsorb vinblastine has been used to treat patients with immune thrombocytopenia. It is hypothesized that the drug-platelet complex is coated with antibody, taken up by macrophages which are then destroyed by the drug. We gave 16 courses of vinblastine-platelets to six patients with immune t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kelton JG,McDonald JW,Barr RM,Walker I,Nicholson W,Neame PB,Hamid C,Wong TY,Hirsh J

    更新日期:1981-03-01 00:00:00

  • RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection.

    abstract::While the interferon (IFN)-inducible double-stranded RNA (dsRNA)-dependent protein kinase PKR is reported to initiate apoptosis in some instances, the mechanism by which diverse stress stimuli activate PKR remains unknown. Now we report that RAX, the only known cellular activator for PKR, initiates PKR activation in r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-11-006817

    authors: Bennett RL,Blalock WL,Abtahi DM,Pan Y,Moyer SA,May WS

    更新日期:2006-08-01 00:00:00

  • Characterization and purification of a primitive hematopoietic cell type in adult mouse marrow capable of lymphomyeloid differentiation in long-term marrow "switch" cultures.

    abstract::In this report, we describe a modification of the assay for long-term culture-initiating cells (LTC-IC) that allows a subset of murine LTC-IC (designated as LTC-ICML) to express both their myeloid (M) and lymphoid (L) differentiative potentials in vitro. The modified assay involves culturing test cells at limiting dil...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lemieux ME,Rebel VI,Lansdorp PM,Eaves CJ

    更新日期:1995-08-15 00:00:00

  • Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.

    abstract::The role of glycosylated recombinant human granulocyte colony-stimulating factor (G-CSF) in the induction treatment of older adults with acute myeloid leukemia (AML) is still uncertain. In this trial, a total of 722 patients with newly diagnosed AML, median age 68 years, were randomized into 4 treatment arms: (A) no G...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood-2004-09-3728

    authors: Amadori S,Suciu S,Jehn U,Stasi R,Thomas X,Marie JP,Muus P,Lefrère F,Berneman Z,Fillet G,Denzlinger C,Willemze R,Leoni P,Leone G,Casini M,Ricciuti F,Vignetti M,Beeldens F,Mandelli F,De Witte T,EORTC\/GIMEMA Leukemi

    更新日期:2005-07-01 00:00:00

  • Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetate.

    abstract::There is considerable interest in identifying nontoxic differentiation inducers for the treatment of various malignant and nonmalignant blood disorders, including inborn beta-chain hemoglobinopathies. Using the human leukemic K562 cell line as a model, we explored the efficacy of phenylacetate, an amino acid derivativ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Samid D,Yeh A,Prasanna P

    更新日期:1992-09-15 00:00:00

  • Inhibitory effect of granulocyte-macrophage colony-stimulating factor therapy on the generation of natural killer cells.

    abstract::We investigated the effects of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) therapy on the natural killer (NK) cell lineage in patients with aplastic anemia and myelodysplastic syndrome. Selected bone marrow (BM) cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Shibuya A,Taguchi K,Kojima H,Abe T

    更新日期:1991-12-15 00:00:00

  • How I treat infant leukemia.

    abstract::Leukemia in infants is rare but generates tremendous interest due to its aggressive clinical presentation in a uniquely vulnerable host, its poor response to current therapies, and its fascinating biology. Increasingly, these biological insights are pointing the way toward novel therapeutic approaches. Using represent...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2018-04-785980

    authors: Brown P,Pieters R,Biondi A

    更新日期:2019-01-17 00:00:00

  • CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia.

    abstract::Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with a complex pathogenesis, which includes both antibody- and T-cell-mediated effector mechanisms. Rituximab (an anti-human CD20 monoclonal antibody [mAb]) is one of the treatments for ITP and is known to deplete B cells but may also work by affecting t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-06-655126

    authors: Guo L,Kapur R,Aslam R,Speck ER,Zufferey A,Zhao Y,Kim M,Lazarus AH,Ni H,Semple JW

    更新日期:2016-02-11 00:00:00

  • Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity.

    abstract::Some B-cell neoplasms, including hairy cell leukemia (HCL), lack expression of the adhesion molecule leukocyte function antigen-1 (LFA-1/CD11a). Additionally, HCL cells express relatively low amounts of intercellular adhesion molecule-1 (ICAM-1/CD54) and may therefore be an inappropriate target for recognition by T ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jansen JH,van der Harst D,Wientjens GJ,Kooy-Winkelaar YM,Brand A,Willemze R,Kluin-Nelemans HC

    更新日期:1992-07-15 00:00:00

  • Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer.

    abstract::Recent studies with long-term mouse marrow cultures have indicated the importance of the adherent layer as a primary reservoir of the most primitive stem cells, from which derivative stem cells and more differentiated progenitors are continuously generated. We have now examined the role of the adherent cell layer in l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Coulombel L,Eaves AC,Eaves CJ

    更新日期:1983-08-01 00:00:00

  • Putative oncogenic role of the erythropoietin receptor in murine and human erythroleukemia cells.

    abstract::To determine whether the erythropoietin receptor (Epo-R) plays a role in the course of malignant erythropoietic disorders, this gene was studied in murine and human erythroleukemia cells. An altered Epo-R gene was found in a murine Friend erythroleukemia cell line, FCL1, due to a spleen focus-forming virus (SFFV) long...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chretien S,Moreau-Gachelin F,Apiou F,Courtois G,Mayeux P,Dutrillaux B,Cartron JP,Gisselbrecht S,Lacombe C

    更新日期:1994-04-01 00:00:00

  • Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B.

    abstract::Factor IXAlabama is a variant factor IX molecule responsible for a clinically moderate form of hemophilia B. Twenty-five kilobases (kb) of the variant gene, including seven exons coding for the structural protein, were cloned and characterized. The restriction map and the arrangement of coding regions are identical to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Davis LM,McGraw RA,Ware JL,Roberts HR,Stafford DW

    更新日期:1987-01-01 00:00:00

  • VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.

    abstract::In human follicular lymphoma the t(14; 18) chromosome translocation activates the antiapoptotic oncogene Bcl2 by linking it to the immunoglobulin heavy chain (IGH) locus. Transgenic mice expressing Bcl2 controlled by an Igh enhancer (E mu) do not develop follicular lymphoma, although they do have an increased incidenc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2469

    authors: Egle A,Harris AW,Bath ML,O'Reilly L,Cory S

    更新日期:2004-03-15 00:00:00

  • Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review.

    abstract::Several strategies can be used to manage fetal or neonatal alloimmune thrombocytopenia (FNAIT) in subsequent pregnancies. Serial fetal blood sampling (FBS) and intrauterine platelet transfusions (IUPT), as well as weekly maternal IV immunoglobulin infusion (IVIG), with or without additional corticosteroid therapy, are...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-10-739656

    authors: Winkelhorst D,Murphy MF,Greinacher A,Shehata N,Bakchoul T,Massey E,Baker J,Lieberman L,Tanael S,Hume H,Arnold DM,Baidya S,Bertrand G,Bussel J,Kjaer M,Kaplan C,Kjeldsen-Kragh J,Oepkes D,Ryan G

    更新日期:2017-03-16 00:00:00

  • Demonstration of reversible priming of human neutrophils using platelet-activating factor.

    abstract::Exposure of neutrophils to agents such as lipopolysaccharide, tumor necrosis factor-alpha (TNF-alpha), and the granulocyte-macrophage colony-stimulating factor causes a major upregulation of subsequent agonist-induced NADPH oxidase activation. This priming effect is a prerequisite for neutrophil-mediated tissue damage...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kitchen E,Rossi AG,Condliffe AM,Haslett C,Chilvers ER

    更新日期:1996-12-01 00:00:00

  • Red blood cells inhibit apoptosis of human neutrophils.

    abstract::Oxidative stress has been implicated in the triggering of apoptosis in neutrophils. Because red blood cells (RBCs) are well known to scavenge oxidants including H2O2, we tested the hypothesis that RBCs inhibit apoptosis of neutrophils by reducing intracellular oxidative stress. Apoptosis of neutrophils was evaluated b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Aoshiba K,Nakajima Y,Yasui S,Tamaoki J,Nagai A

    更新日期:1999-06-01 00:00:00

  • Human interleukin-3 mRNA accumulation is controlled at both the transcriptional and posttranscriptional level.

    abstract::Interleukin-3 (IL-3) is a hematopoietic growth factor that regulates the differentiation of multilineage and committed progenitor cells and the functions of some mature blood cells. The expression of human IL-3 appears to be restricted to stimulated T lymphocytes. We have investigated the kinetics and mechanisms invol...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ryan GR,Milton SE,Lopez AF,Bardy PG,Vadas MA,Shannon MF

    更新日期:1991-03-15 00:00:00